FREDERICK, Md., Sept. 3, 2025 /PRNewswire/ -- BioFactura, Inc., a clinical‐stage biopharmaceutical company specializing in high‐value biosimilars and critical biodefense medical countermeasures, today announced the formation of Capitol Biologics, a new Contract Development and...